Part 1: Presented by Raj Sheel, VP of Business Development and Marketing

Part 3: Presented by Justin M. Keen, PhD, VP of Operations

Part 2: Presented by Dave A. Miller, PhD, VP of Research & Development

Part 4: Presented by Chris Brough, MBA, PhD, VP of Technology

Part 1: Enhanced Amorphous Solid Dispersion with KinetiSol®: Industry Case Studies

Part 3: Use of KinetiSol® in the Development of Oncology Assets

Part 2: KinetiSol® Processed ASDs: Performance in vivo and in non-clinical safety studies

Part 4: Case Studies on Enhancing Therapeutic Efficacy via Reformulation with KinetiSol®